
EU Drug Regulator Backs New Cancer Therapies and Rare Disease Treatments
Europe’s medicines regulator, the European Medicines Agency (EMA), has recommended approval for several new treatments, including three cancer therapies targeting aggressive forms of the disease, alongside other innovative medicines for serious conditions.

